Anatara Lifesciences Ltd (ASX:ANR)
Australia flag Australia · Delayed Price · Currency is AUD
0.0050
0.00 (0.00%)
Apr 24, 2025, 3:07 PM AEST

Anatara Lifesciences Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
1834116
Upgrade
Market Cap Growth
171.52%139.08%-14.44%-63.95%67.98%-48.56%
Upgrade
Enterprise Value
072172
Upgrade
Last Close Price
0.010.040.030.050.140.12
Upgrade
PS Ratio
4.68-----
Upgrade
PB Ratio
0.875.883.632.882.842.27
Upgrade
P/TBV Ratio
0.875.883.632.882.842.27
Upgrade
EV/Sales Ratio
0.29-----
Upgrade
Debt / Equity Ratio
---0.050.02-
Upgrade
Asset Turnover
0.16-----
Upgrade
Quick Ratio
4.295.442.844.6910.447.14
Upgrade
Current Ratio
4.425.492.874.7510.547.19
Upgrade
Return on Equity (ROE)
-147.32%-126.79%-176.79%-97.50%-59.70%-76.71%
Upgrade
Return on Assets (ROA)
-76.06%-59.01%-80.22%-51.99%-33.28%-45.22%
Upgrade
Return on Capital (ROIC)
-92.48%-79.68%-108.57%-59.34%-37.72%-50.14%
Upgrade
Earnings Yield
-164.72%-18.08%-60.25%-64.52%-18.33%-51.91%
Upgrade
FCF Yield
--15.54%-67.29%-57.06%-19.30%-42.11%
Upgrade
Buyback Yield / Dilution
-52.75%-53.21%-37.65%-13.44%-26.25%-0.52%
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.